Eisspeedway

Glibenclamide/metformin

Glibenclamide/metformin
Combination of
GlibenclamideSulfonylurea
MetforminBiguanide
Clinical data
Trade namesGlucovance
AHFS/Drugs.comMonograph
MedlinePlusa699055
License data
Pregnancy
category
Routes of
administration
By mouth
ATC code
  • None
Legal status
Legal status
Identifiers
CAS Number
KEGG

Glibenclamide/metformin, also known as glyburide/metformin and sold under the brand name Glucovance, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes.[6] It contains glibenclamide, a sulfonylurea, and metformin, a biguanide.[7]

References

  1. ^ a b "TGA eBS - Product and Consumer Medicine Information Licence". Archived from the original on 23 March 2022. Retrieved 30 April 2022.
  2. ^ "Search the TGA website".
  3. ^ "Search the TGA website".
  4. ^ "Search the TGA website". Archived from the original on 30 April 2022. Retrieved 30 April 2022.
  5. ^ "Glucovance- glyburide and metformin hydrochloride tablet, film coated". DailyMed. 23 April 2012. Archived from the original on 30 April 2022. Retrieved 30 April 2022.
  6. ^ Lamos EM, Stein SA, Davis SN (December 2012). "Combination of glibenclamide-metformin HCl for the treatment of type 2 diabetes mellitus". Expert Opinion on Pharmacotherapy. 13 (17): 2545–54. doi:10.1517/14656566.2012.738196. PMID 23116560. S2CID 10305382.
  7. ^ "Glyburide and metformin hydrochloride tablet". DailyMed. 10 June 2020. Archived from the original on 26 February 2021. Retrieved 11 August 2020.